INTERNATIONAL PATENT: INVOX PHARMA LIMITED FILES APPLICATION FOR "DOSAGE REGIMES FOR THE ADMINISTRATION OF AN ANTI-CD137/PD-L1 ANTIGEN-BINDING PROTEIN"

GENEVA, Dec. 1 -- INVOX PHARMA LIMITED (Suite 2, First Floor, The Westworks195 Wood LaneWhite City PlaceLondon W12 7FQ) filed a patent application (PCT/EP2025/064221) for "DOSAGE REGIMES FOR THE ADMINISTRATION OF AN ANTI-CD137/PD-L1 ANTIGEN-BINDING PROTEIN" on May 22, 2025. With publication no. WO/2025/242842, the details related to the patent application was published on Nov 27, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LAKINS, Matthew (c/o INVOX PHARMA LIMITEDSuite 2, First Floor, The Westworks195 Wood Lane, White City PlaceLondon W12 7FQ), JONES, Daniel (c/o INVOX PHARMA LIMITEDSuit...